Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'
Cephalalgia
.
2024 Oct;44(10):3331024241293104.
doi: 10.1177/03331024241293104.
Authors
Linda Al-Hassany
1
,
Deirdre M Boucherie
1
,
Emile G M Couturier
2
,
Antoinette MaassenVanDenBrink
1
Affiliations
1
Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
2
Department of Neurology/Clinical Neurophysiology, Neurologie Centrum Amsterdam, Amsterdam, The Netherlands.
PMID:
39445402
DOI:
10.1177/03331024241293104
No abstract available
Publication types
Letter